OBJECTIVE To construct specialized file management and risk warning system for narcotic drugs， and promote the refined management of narcotic drugs in medical institutions. METHODS Through the rational medication management system， patient-indexed narcotic drug medication record information was integrated， pain assessment and rapid dose titration modules were constructed， and a prescription pre-review risk warning model was established. Statistical analysis was conducted on the number of drugs returned by patients， interventions for adverse events related to narcotic drug abuse， patient and physician satisfaction， and patient medication adherence before the system was constructed （January-July 2023） and after its stable operation （January-July 2024）. RESULTS After the construction of the system， the number of narcotic drugs returned by patients decreased， except for Morphine tablets. The number of interventions for adverse events related to narcotic drug abuse increased from 0 to 5 cases. The patients’ satisfaction with pain control increased from 46.25% to 67.50%， the proportion of patients with poor adherence decreased from 23.75% to 7.50%， and the overall satisfaction of physicians was 72.41%. CONCLUSIONS The construction of a specialized file management and risk warning system for narcotic drugs enables refined management of narcotic drugs， provides alerts for abnormal prescriptions， reduces patient stockpiling of narcotic drugs， allows timely detection and intervention of adverse events related to narcotic drug abuse， improves physician treatment efficiency and precision， and enhances patient pain control satisfaction and medication adherence.

OBJECTIVE To explore the key points of pharmaceutical care of drug-induced hypersensitivity syndrome caused by vancomycin. METHODS The clinical pharmacists performed pharmaceutical care for a case of vancomycin-induced drug hypersensitivity syndrome in a child, adjusted the child′s medication regimens, monitored antimicrobial blood concentrations and adjusted the administered dose, and performed a relevant literature analysis. RESULTS After early identification and discontinuation of the suspected sensitizing drugs, the child was discharged from the hospital after symptomatic supportive treatment. CONCLUSION Children with drug-induced hypersensitivity syndrome have the special characteristics of children, clinicians and clinical pharmacists should focus on the medication safety of the special group to achieve early detection and early treatment.